← Back to modules
Module 03  ·  Live

eGovS — Electronic Government
Savviness

Monitor how engaged legislators are on pharmaceutical and health topics worldwide. Track social media sentiment, parliamentary speeches, bill activity, and committee positions — all scored in real time with temporal decay.

20+
Countries monitored
200+
Products tracked
35
Pharma manufacturers
5
Social platforms analysed
Live Demos

Have a taste of what eGovS can do

One interactive cockpit — no login required. Click and explore.

The Reality

What the industry faces without it

Legislative blind spots cost pharma billions in delayed approvals, surprise policy shifts, and missed advocacy windows.

$4.2B
Annual revenue at risk from unexpected legislative or regulatory policy shifts across major pharmaceutical markets.
72%
Of government affairs teams report lacking real-time visibility into legislator positions on health topics.
80+
Health authorities worldwide whose legislative activity directly impacts drug pricing, access, and reimbursement policy.
6–12 mo
Typical lag between a policy shift signal and industry response — eGovS closes this gap to days.
Capabilities

Complete legislative visibility

eGovS delivers real-time intelligence on legislator engagement — from social media sentiment to committee influence and bill tracking.

Sentiment Analysis
Social Media Scoring

Track legislator sentiment across LinkedIn, Twitter, Facebook, Instagram, and TikTok. Platform-weighted scoring with temporal decay captures evolving positions in real time.

Legislative Tracking
Bill & Speech Monitoring

Score congressional speeches for topic relevance and track favorable vs opposing bills. Additive scoring reveals legislative momentum for or against your therapeutic area.

Committee Intelligence
Committee Position Mapping

Map committee memberships with tiered influence weights — chairs, full members, and subcommittee members — adjusted by country influence on global pharmaceutical policy.

Global View
Country & Regional Dashboards

Toggle between country, regional, and global views. Interactive D3 world map with 20 countries, manufacturer filtering, and free-text topic search across all data.

The Strategic Imperative

Why eGovS exists

$4.2B
Annual pharma revenue exposed to legislative and regulatory blind spots
20+
Countries with active health committee oversight directly affecting drug market access
Faster response to policy shifts compared to traditional government affairs monitoring
Get Started

Request access to eGovS

Join pharma and medtech teams using eGovS to anticipate legislative shifts and engage proactively.

Request Early Access